151 related articles for article (PubMed ID: 12973852)
1. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
[TBL] [Abstract][Full Text] [Related]
2. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
3. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors.
Li AF; Li AC; Tsay SH; Li WY; Liang WY; Chen JY
Am J Clin Pathol; 2008 Oct; 130(4):535-42. PubMed ID: 18794045
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of p16INK4a and p53 overexpression in endocrine tumors of the gastrointestinal tract.
Li AF; Tsay SH; Liang WY; Li WY; Chen JY
Am J Clin Pathol; 2006 Dec; 126(6):856-65. PubMed ID: 17074692
[TBL] [Abstract][Full Text] [Related]
6. Allelotypes and fluorescence in situ hybridization profiles of poorly differentiated endocrine carcinomas of different sites.
Furlan D; Bernasconi B; Uccella S; Cerutti R; Carnevali I; Capella C
Clin Cancer Res; 2005 Mar; 11(5):1765-75. PubMed ID: 15755998
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors.
Hessman O; Lindberg D; Einarsson A; Lillhager P; Carling T; Grimelius L; Eriksson B; Akerström G; Westin G; Skogseid B
Genes Chromosomes Cancer; 1999 Nov; 26(3):258-64. PubMed ID: 10502325
[TBL] [Abstract][Full Text] [Related]
9. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
[TBL] [Abstract][Full Text] [Related]
10. Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.
Mori M; Mimori K; Masuda T; Yoshinaga K; Yamashita K; Matsuyama A; Inoue H
Cancer Res; 2001 Oct; 61(20):7379-82. PubMed ID: 11606365
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.
Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P
Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
Grundei T; Vogelsang H; Ott K; Mueller J; Scholz M; Becker K; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2000 Dec; 6(12):4782-8. PubMed ID: 11156235
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
[TBL] [Abstract][Full Text] [Related]
16. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst.
Malcić A; Jukić S; Anić I; Pavelić B; Kapitanović S; Kruslin B; Pavelić K
J Oral Pathol Med; 2008 May; 37(5):294-301. PubMed ID: 18221322
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
18. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
19. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
Geradts J; Fong KM; Zimmerman PV; Minna JD
Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
[TBL] [Abstract][Full Text] [Related]
20. Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene.
Ohki S; Onda M; Fukushima T; Takita K; Suzuki S; Hoshino M; Tsuchiya A; Abe R; Takenoshita S
Int J Mol Med; 2003 Apr; 11(4):485-90. PubMed ID: 12632102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
